Physical Performance and Quality of Life in Children With Brain Tumors

September 3, 2026 updated by: Sarah Mohammed El-Abasiri

ASSESSMENT OF PHYSICAL PERFORMANCE AND QUALITY OF LIFE IN CHILDREN WITH BRAIN TUMORS.

This study is designed to assess physical performance and quality of life in children with posterior fossa brain tumors compared to healthy children. The trial evaluates parameters such as physical endurance, balance, muscle strength, gait characteristics, and quality of life measures to understand the functional impact of the condition.

Study Overview

Study Type

Observational

Enrollment (Estimated)

60

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Contact

Study Locations

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

  • Child

Accepts Healthy Volunteers

Yes

Sampling Method

Non-Probability Sample

Study Population

Pediatric patients diagnosed with posterior fossa brain tumors recruited from treatment centers, alongside an age-matched group of healthy children serving as controls.

Description

Inclusion Criteria:

  • - Children aged 7 to 10 years.
  • Confirmed diagnosis of posterior fossa brain tumors.
  • Medically stable and able to perform physical evaluations.

Inclusion Criteria for Healthy Controls:

  • Age-matched healthy children aged 7 to 10 years.
  • No history of neurological, musculoskeletal, or oncological disorders.

Exclusion Criteria:

  • Associated severe cognitive or visual impairments preventing test comprehension.
  • Other concurrent major medical or orthopedic conditions affecting physical performance.

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

Cohorts and Interventions

Group / Cohort
Posterior Fossa Brain Tumor Group
Children aged 7 to 10 years diagnosed with posterior fossa brain tumors.
Healthy Control Group
Age-matched healthy children acting as a control group.

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
6-Minute Walk Test (6MWT)
Time Frame: At baseline during the initial assessment
Measures walking distance in meters to evaluate physical endurance and functional capacity.
At baseline during the initial assessment

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Collaborators

Investigators

  • Principal Investigator: Eman Ibrahim Elhadidy, Cairo University Faculty of Physical Therapy

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Actual)

December 1, 2025

Primary Completion (Estimated)

December 1, 2026

Study Completion (Estimated)

December 25, 2026

Study Registration Dates

First Submitted

September 3, 2026

First Submitted That Met QC Criteria

September 3, 2026

First Posted (Actual)

September 9, 2026

Study Record Updates

Last Update Posted (Actual)

September 9, 2026

Last Update Submitted That Met QC Criteria

September 3, 2026

Last Verified

September 1, 2026

More Information

Terms related to this study

Other Study ID Numbers

  • P.T.REC/012/006217

Plan for Individual participant data (IPD)

Plan to Share Individual Participant Data (IPD)?

NO

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Subscribe